Endocrine and immune effects of melatonin therapy in metastatic cancer patients
- 31 May 1989
- journal article
- Published by Elsevier BV in European Journal of Cancer and Clinical Oncology
- Vol. 25 (5), 789-795
- https://doi.org/10.1016/0277-5379(89)90122-3
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 AloneThe New England Journal of Medicine, 1987
- A clinical study of the pineal gland activity in oncologic patientsCancer, 1986
- Enkephalins as immunomodulatorsInternational Journal of Immunopharmacology, 1983
- Apparent involvement of opioid peptides in stress-induced enhancement of tumor growthPeptides, 1983
- Effect of melatonin on experimental tumors under different photoperiods and times of administrationJournal of Neural Transmission, 1981
- Psychoneuroendocrine Influences on Immunocompetence and NeoplasiaScience, 1981
- Effect of pinealectomy and melatonin on mammary tumor growth in sprague-dawley rats under different conditions of lightingJournal of Neural Transmission, 1980
- THE PINEAL AND NEOPLASIAThe Lancet, 1975
- Stimulation and suppression of somatomedin activity by serotonin and melatoninCellular and Molecular Life Sciences, 1974
- Role of pinealectomy on Walker 256 carcinoma in ratsJournal of Surgical Oncology, 1970